1st Feb 2006 07:02
International Medical Devices PLC01 February 2006 International Medical Devices starts safe needle trials with NHS International Medical Devices (IMD or 'the Company') is pleased to announce thatits range of safe needles and syringes is to undergo clinical tests with theNational Health Service with delivery of supplies into the NHS scheduled tofollow immediately. Marketing of the devices is being conducted by IMD'swholly-owned subsidiary Meddis Ltd which is an existing approved supplier to theNHS. A number of retractable and novel safe devices are being tested. IMD isconfident that its products will meet the NHS's needs both in terms of quality,clinical efficiency and price. Until now the cost of so-called safe devices hasbeen a prohibitive factor for health authorities but all products offered by IMDwill be at a small premium over conventional needles currently used and willundercut existing devices from other manufacturers. Needlestick accidents are the second biggest cause of injuries to health workersin both the NHS and private sectors. There are 40,000 reported needlestickaccidents a year in the UK and it is thought as many again go unreported. They account for 17 per cent of accidents to NHS staff. Contaminated needles cantransmit more than 20 dangerous blood-borne pathogens including hepatitis B andC and HIV. According to the NHS at least four healthcare workers have diedfollowing occupationally acquired HIV infection*. Recent cases, including onebrought by Unison against the Scottish NHS, have highlighted the need for thewidespread use of safe devices. The NHS is keen to see widespread use of safety devices for all its "frontline"staff before expected legislation is introduced to make safe needlescompulsory. * The Management of Health, Safety and Welfare Issues. NHS 2005 About IMD: International Medical Devices plc was founded to exploit opportunities in themedical devices market, initially in the UK and Europe. It was admitted to AIMon November 10, 2004 and in July it acquired a range of technology patents,including those covering safe needles, from Eastland Technology Australia Ltdand distribution rights from Eastland Medical Systems Ltd. In September theCompany acquired the entire share capital of Meddis Ltd, a distributor of acutecare medical devices. www.imd-plc.com Further information: Chris Thomas, IMD: 0207 659 5216 Alan Frame, Westport Communications: 0207 405 7777 or 07850 944187 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Intelliam Ai